GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Celemics Inc (XKRX:331920) » Definitions » Research & Development

Celemics (XKRX:331920) Research & Development : ₩1,139 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Celemics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Celemics's Research & Development for the three months ended in Mar. 2024 was ₩218 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ₩1,139 Mil.


Celemics Research & Development Historical Data

The historical data trend for Celemics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celemics Research & Development Chart

Celemics Annual Data
Trend Dec15 Dec16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 1,750.64 1,491.49 2,658.93 2,211.35 1,307.65

Celemics Quarterly Data
Mar19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 386.42 346.01 346.40 228.82 217.69

Celemics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,139 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Celemics  (XKRX:331920) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Celemics Research & Development Related Terms

Thank you for viewing the detailed overview of Celemics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Celemics (XKRX:331920) Business Description

Traded in Other Exchanges
N/A
Address
131 Gasandigital 1-ro, Geumcheon-gu, 19-20 Floor, Building A, BYC Highcity, Seoul, KOR, 08506
Celemics Inc is a manufacturer of Next Generation Sequencing test kit. It offers, develops and manufactures proprietary DNA and genetic sequencing test kits and panels. Its products include Targeted Sequencing Kit, NGS Library Preparation Kit, and XSEP MagBead.

Celemics (XKRX:331920) Headlines

No Headlines